News
Academy
Publications
All Publications
eBooks
Media
Editorial Podcasts
Editorial Videos
Peer Exchange
Practice Academy
Shorts
Sponsored Podcasts
Sponsored Videos
More
Conferences
Conference Coverage
Conference Listing
Columns
All Columns
A Closing Thought
Clinical Trial Insights
View from Brussels
View from Washington
Resources
Advertise
Blogs
Events
Front & Center
Partner Perspectives
White Papers
Events
Webcasts
Event Calendar
Subscribe
My Account
News
Academy
Publications
Media
Conferences
Columns
Resources
Events
Subscribe
Event Calendar
Clinical Operations & Strategy
Decentralized Clinical Trials
Trial Design
Investigative Sites
CRO/Sponsor
Risk-Based Monitoring
Protocol Design
Clinical Trial Supply Chain
Study Start-Up
Early Phase Development
DEI
Industry Initiatives
Diversity Action Plans
Recruitment
Data Management
Analytics
Electronic Data Capture
Real World Evidence
Metrics & Benchmarks
Patient Participation
Integrated Research
CRAACO
Enrollment
Regulatory
Institutional Review Board & Ethics Committee
FDA
EMA
Technology
Artificial Intelligence/Machine Learning
eClinical
mHealth
Choose Specialty
Spotlight -
Conference Coverage
|
Peer Exchange
|
DE&I
|
Editorial Videos
|
Clinical Operations & Strategy
|
Patient Participation
Advertisement
Trina Slabiak
Advertisement
Articles by Trina Slabiak
Clinical Trial Endpoints for Oncology Studies
By
Trina Slabiak
April 2nd 2012
Applied Clinical Trials
Advertisement
Latest Updated Articles
Clinical Trial Endpoints for Oncology Studies
April 2nd 2012
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal
2
Agentic AI and the Administrative Backbone of Clinical Trials: Why the Operating Model Has to Change First
3
FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data
4
Why Time Savings Is the Largest Driver of RBQM's Financial Value
5
AI Moves Patient Recruitment from Trial Bottleneck to Competitive Edge: A 2026 Perspective